Germline Analysis From Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-0015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

JAMA network open
Medicine
2020English

Tumor Sequencing Is Useful to Refine the Analysis of Germline Variants in Unexplained High-Risk Breast Cancer Families

Breast Cancer Research
Cancer ResearchOncology
2020English

Desktop Transcriptome Sequencing From Archival Tissue to Identify Clinically Relevant Translocations

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2013English

Shaping of Human Germline IgH Repertoires Revealed by Deep Sequencing

Journal of Immunology
AllergyImmunology
2012English

Tracking Tumor Kinetics in Patients With Germline CYLD Mutations

Journal of the American Academy of Dermatology
Dermatology
2018English

Exome Sequencing Identifies Germline Variants in DIS3 in Familial Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

Germline Mutation Contribution to Chromosomal Instability

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2017English

Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma

American Journal of Human Genetics
Genetics
2019English

Exome Sequencing of Cell-Free DNA From Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct From Primary Disease

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy